Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/26/2003US20030119107 Prevent aggregation of embryos stem cells; controlling by encapsulation
06/26/2003US20030119106 Fusion proteins; binding to antibodies
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119103 Fusion proteins; binding to antibodies
06/26/2003US20030119098 Plant extract; hybrid nucleic acids; genetic engineering; polymerase chain reactions cycles
06/26/2003US20030119097 Anticancer agents; screening genetic engineered libraries
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119088 Phosphorylation of proteins; therapy for lysosome storage disease
06/26/2003US20030119086 Binding to antibodies, cell proliferation, cell differentiation
06/26/2003US20030119085 Substrates for beta-lactamase and uses thereof
06/26/2003US20030119080 Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
06/26/2003US20030119078 Method of reducing immunogenicity of toxicity of an antibody of IgG class
06/26/2003US20030119077 Method of enriching rare cells
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119070 Complexing ligand, peptide ; displacement of one ligand with another
06/26/2003US20030119067 PYK2 related products and methods
06/26/2003US20030119057 Forming and modifying dielectrically-engineered microparticles
06/26/2003US20030119055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119049 Cytometry, quantitative analysis; aqueous solutions; prevent degradation
06/26/2003US20030119045 Controlling cell proliferation; adjust adhesion to substrate
06/26/2003US20030119039 Detection using antibodies
06/26/2003US20030119033 Immunoassay using antibodies
06/26/2003US20030119029 Apoptosis, autoimmune diseases, antiproliferative agents, antiinflammatory agents, anticancer agents
06/26/2003US20030119024 Measurement variations in gene expression; calibrating patterns
06/26/2003US20030119018 Novel polynucleotides
06/26/2003US20030119017 Anticancer agents, antiinflammatory agents, autoimmune disease; modulation of gene expression; nuclear factor kappa B
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030119009 Genes regulated by MYCN activation
06/26/2003US20030119006 Transforming cells with gene expression vector; genetic engineering
06/26/2003US20030119001 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
06/26/2003US20030118988 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
06/26/2003US20030118677 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/26/2003US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination
06/26/2003US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection
06/26/2003US20030118600 Transfer compounds, production and use thereof
06/26/2003US20030118596 Fusion proteins economically synthesized in plants at high levels by biologically contained tobamoviruses; use as antigens for inducing production of antibodies or as vaccine antigens for induction of immunity against parvovirus
06/26/2003US20030118573 MB-1 analogs and uses thereof
06/26/2003US20030118570 Vectors for tissue-specific replication
06/26/2003US20030118569 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003US20030118568 Viral stealth technology to prevent T cell-mediated rejection of xenografts
06/26/2003US20030118567 Cell-based therapy for the pulmonary system
06/26/2003US20030118566 Differentiating the obtained central nervous system (CNS) stem cells by culturing stems cells in vitro in differentiation medium containing fibroblast growth factor 8 and glial cell line derived neurotrophic factor, transplanting them into CNS
06/26/2003US20030118565 Treatment of muscular dystrophy with cord blood cells
06/26/2003US20030118563 Materials and methods for repair of tissue
06/26/2003US20030118562 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
06/26/2003US20030118559 Contacting the bodily fluid of a patient with renal tubule cells outside of the kidney for treating systemic inflammatory response syndrome (SIRS)
06/26/2003US20030118556 Transducing neuron with gene; muscular disorders
06/26/2003US20030118554 Helper dependent adenovirus vectors based on integrase family site-specific recombinases
06/26/2003US20030118552 Targeted retrograde gene delivery for neuronal protection
06/26/2003US20030118551 Modified viral surface proteins for binding to extracellular matrix components
06/26/2003US20030118487 Vertical holding trays; rotation; automatic analyzing system
06/26/2003CA2801859A1 Phospholipid:diacylglycerol acyltransferases
06/26/2003CA2473085A1 Method for controlled induction of somatic mutations and use thereof in proteomics
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471251A1 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003CA2470621A1 Bgl4 beta-glucosidase and nucleic acids encoding the same
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/26/2003CA2470414A1 Egvi endoglucanase and nucleic acids encoding the same
06/26/2003CA2470407A1 Egvii endoglucanase and nucleic acids encoding the same
06/26/2003CA2470401A1 Bgl5 beta-glucosidase and nucleic acids encoding the same
06/26/2003CA2470026A1 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2469740A1 Device for active phase cell or tissue sampling and uses thereof
06/26/2003CA2469611A1 Cell constructs cultured in vitro, preparation and uses
06/26/2003CA2469572A1 Egviii endoglucanase and nucleic acids encoding the same
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2467638A1 Cryopreservation of biological materials using pre-chilled protectant
06/26/2003CA2459661A1 Insect g protein-coupled receptor genes and uses thereof
06/26/2003CA2456210A1 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
06/25/2003EP1321523A2 Selection marker gene free recombinant strains; a method for obtaining them and the use of these strains
06/25/2003EP1321518A1 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
06/25/2003EP1321516A2 Hydrogel matrix for cellular tissue storage
06/25/2003EP1321515A1 Method of culturing cells
06/25/2003EP1321477A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/25/2003EP1321034A1 Disruption of the phosphodieterase 10 gene
06/25/2003EP1321033A1 Transgenic expression of glycogen synthase kinase 3 in muscle
06/25/2003EP1320752A2 Differential treatment of selected parts of a single cell with different fluid components
06/25/2003EP1320750A2 Methods for identifying agents causing a lethal phenotype
06/25/2003EP1320627A2 Mitochondrial dosimeter
06/25/2003EP1320623A1 Promoter sequences
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320617A1 Genetic engineering of syringyl-enriched lignin in plants
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320613A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/25/2003EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320585A2 Oxidoreductases
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320583A2 Enhanced replication of hcv rna
06/25/2003EP1320581A1 T cell receptor transfer into a candidate effector cell or a precursor thereof
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320548A2 Transporters and ion channels
1 ... 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 ... 1827